Shareo.

ZTS · bullish

Called by Equity Mates Investing Podcast on 2026-07-12

“So Zoetis, New York Stock Exchange ticket, zed t s. It's a global leader in animal pharmaceuticals. It's about a $50,000,000,000 company. It makes a lot of the pet pharmaceuticals, the drugs that vets prescribe, I guess, as pets get older.”

No settled horizons yet — outcomes appear at 30/90/365 days.

Risk: max drawdown 3.5% · volatility 24.2% ann. · Sharpe-proxy -0.85